Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Serum-Free Freezing Media Market by Type (With DMSO, DMSO-free), By Application (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Serum-Free Freezing Media Market by Type (With DMSO, DMSO-free), By Application (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 171197 3300 Pharma & Healthcare 377 241 Pages 4.6 (32)
                                          

Market Overview:


The global serum-free freezing media market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for serum-free freezing media from academic and research institutes, pharmaceutical and biotechnology companies, and other end users. Serum-free freezing media are used for the cryopreservation of cells, tissues, organs, and embryos. They are also used for the storage of biological samples such as blood products and stem cells. The use of serum-free freezing media helps in reducing contamination risks and improves cell viability rates.


Global Serum-Free Freezing Media Industry Outlook


Product Definition:


Serum-free freezing media is a type of media that does not contain any serum. Serum is a fluid that contains proteins, such as antibodies, and other molecules derived from blood.


With DMSO:


With DMSO, it's usage.


With DMSO, it's usage.


DMSO-free:


DMSO-free and its usage in serum-free freezing media is a new concept. DMSO, or dimethyl sulfoxide, is widely used as an anti-microbial agent in the pharmaceutical industry. However, it has several side effects such as nausea and diarrhea when used internally.


Application Insights:


Based on the application, the market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, tissue banking facilities, and others. The academic and research institutes segment dominated the global market in 2017. This can be attributed to rising R&D activities at various medical institutions across the globe for developing new products using freezing as a method of preservation.


The demand for frozen human tissues has witnessed tremendous growth over recent years owing to increasing applications in regenerative medicine & stem cell therapy procedures. Moreover, an increase in cosmetic surgeries also contributes toward high product consumption globally. According to L'Orĩal SFTI (Salon Franco-Tĩlĩphonique International), France conducted around 60 million beauty treatments annually; out of which 35% are carried out on women above 50 years of age who have wrinkles due to facial expression or body language caused due to lack of youthful appearance (reconstruction).


Regional Analysis:


North America dominated the global market in 2017 owing to the presence of a large number of pharmaceutical and biotechnology companies involved in R&D activities. The region is expected to maintain its position during the forecast period due to increasing government funding for research projects. In addition, rising incidence of chronic diseases such as cancer, diabetes, & Parkinson’s disease is also anticipated to boost product demand over the forecast period.


Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to an increase in healthcare expenditure by governments along with growing awareness about serum-free freezing media among physicians and surgeons operating on patients requiring immediate surgery or emergency care settings such as hospitals & clinics. Moreover, increasing investments by various organizations for development of new products are also contributing towards regional growth rate. For instance, Novotech Ltd.


Growth Factors:


  • Increasing demand for serum-free freezing media from biotechnology and pharmaceutical companies for the production of vaccines and therapeutics.
  • Growing preference for serum-free freezing media over traditional animal sera due to its superior performance characteristics and lower cost.
  • Proliferation of contract research organizations (CROs) that offer preclinical services, including cryopreservation, is expected to drive the market growth in the coming years.
  • Rising R&D expenditure by pharmaceutical and biotechnology companies on new drug discovery programs is anticipated to boost the demand for serum-free freezing media products over the forecast period.

Scope Of The Report

Report Attributes

Report Details

Report Title

Serum-Free Freezing Media Market Research Report

By Type

With DMSO, DMSO-free

By Application

Academic & Research Institutes, Pharmaceutical & Biotechnology Companies

By Companies

Thermo Fisher, Merck, Zenoaq, STEMCELL, GE Healthcare, BioLifeSolutions, Bio-Techne, Lonza, Biological Industries, Nippon Genetics, HiMedia, PromoCell

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

241

Number of Tables & Figures

169

Customization Available

Yes, the report can be customized as per your need.


Global Serum-Free Freezing Media Market Report Segments:

The global Serum-Free Freezing Media market is segmented on the basis of:

Types

With DMSO, DMSO-free

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Academic & Research Institutes, Pharmaceutical & Biotechnology Companies

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Thermo Fisher
  2. Merck
  3. Zenoaq
  4. STEMCELL
  5. GE Healthcare
  6. BioLifeSolutions
  7. Bio-Techne
  8. Lonza
  9. Biological Industries
  10. Nippon Genetics
  11. HiMedia
  12. PromoCell

Global Serum-Free Freezing Media Market Overview


Highlights of The Serum-Free Freezing Media Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. With DMSO
    2. DMSO-free
  1. By Application:

    1. Academic & Research Institutes
    2. Pharmaceutical & Biotechnology Companies
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Serum-Free Freezing Media Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Serum-Free Freezing Media Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Serum-free freezing media is a type of cryopreservation medium that does not contain serum. This medium is typically used to preserve cells and tissues that are not likely to be affected by the presence of serum, such as cancer cells or stem cells.

Some of the key players operating in the serum-free freezing media market are Thermo Fisher, Merck, Zenoaq, STEMCELL, GE Healthcare, BioLifeSolutions, Bio-Techne, Lonza, Biological Industries, Nippon Genetics, HiMedia, PromoCell.

The serum-free freezing media market is expected to grow at a compound annual growth rate of 7.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Serum-Free Freezing Media Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Serum-Free Freezing Media Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Serum-Free Freezing Media Market - Supply Chain
   4.5. Global Serum-Free Freezing Media Market Forecast
      4.5.1. Serum-Free Freezing Media Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Serum-Free Freezing Media Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Serum-Free Freezing Media Market Absolute $ Opportunity

5. Global Serum-Free Freezing Media Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Serum-Free Freezing Media Market Size and Volume Forecast by Type
      5.3.1. With DMSO
      5.3.2. DMSO-free
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Serum-Free Freezing Media Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Serum-Free Freezing Media Market Size and Volume Forecast by Application
      6.3.1. Academic & Research Institutes
      6.3.2. Pharmaceutical & Biotechnology Companies
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Serum-Free Freezing Media Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Serum-Free Freezing Media Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Serum-Free Freezing Media Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Serum-Free Freezing Media Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Serum-Free Freezing Media Demand Share Forecast, 2019-2026

9. North America Serum-Free Freezing Media Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Serum-Free Freezing Media Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Serum-Free Freezing Media Market Size and Volume Forecast by Application
      9.4.1. Academic & Research Institutes
      9.4.2. Pharmaceutical & Biotechnology Companies
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Serum-Free Freezing Media Market Size and Volume Forecast by Type
      9.7.1. With DMSO
      9.7.2. DMSO-free
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Serum-Free Freezing Media Demand Share Forecast, 2019-2026

10. Latin America Serum-Free Freezing Media Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Serum-Free Freezing Media Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Serum-Free Freezing Media Market Size and Volume Forecast by Application
      10.4.1. Academic & Research Institutes
      10.4.2. Pharmaceutical & Biotechnology Companies
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Serum-Free Freezing Media Market Size and Volume Forecast by Type
      10.7.1. With DMSO
      10.7.2. DMSO-free
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Serum-Free Freezing Media Demand Share Forecast, 2019-2026

11. Europe Serum-Free Freezing Media Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Serum-Free Freezing Media Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Serum-Free Freezing Media Market Size and Volume Forecast by Application
      11.4.1. Academic & Research Institutes
      11.4.2. Pharmaceutical & Biotechnology Companies
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Serum-Free Freezing Media Market Size and Volume Forecast by Type
      11.7.1. With DMSO
      11.7.2. DMSO-free
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Serum-Free Freezing Media Demand Share, 2019-2026

12. Asia Pacific Serum-Free Freezing Media Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Serum-Free Freezing Media Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Serum-Free Freezing Media Market Size and Volume Forecast by Application
      12.4.1. Academic & Research Institutes
      12.4.2. Pharmaceutical & Biotechnology Companies
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Serum-Free Freezing Media Market Size and Volume Forecast by Type
      12.7.1. With DMSO
      12.7.2. DMSO-free
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Serum-Free Freezing Media Demand Share, 2019-2026

13. Middle East & Africa Serum-Free Freezing Media Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Serum-Free Freezing Media Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Serum-Free Freezing Media Market Size and Volume Forecast by Application
      13.4.1. Academic & Research Institutes
      13.4.2. Pharmaceutical & Biotechnology Companies
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Serum-Free Freezing Media Market Size and Volume Forecast by Type
      13.7.1. With DMSO
      13.7.2. DMSO-free
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Serum-Free Freezing Media Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Serum-Free Freezing Media Market: Market Share Analysis
   14.2. Serum-Free Freezing Media Distributors and Customers
   14.3. Serum-Free Freezing Media Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Thermo Fisher
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Merck
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Zenoaq
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. STEMCELL
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. GE Healthcare
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. BioLifeSolutions
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Bio-Techne
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Lonza
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Biological Industries
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Nippon Genetics
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. HiMedia
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. PromoCell
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us